Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure UK residents who have taken part in trials of the Valneva covid-19 vaccine are able to demonstrate to healthcare and other authorities that they are adequately vaccinated against covid-19.
All clinical trial participants can now gain access to a domestic NHS COVID Pass. Clinical trial participants who received the Valneva vaccine as part of their trial will continue to be able to prove their vaccination status and will be treated as fully vaccinated in domestic settings and at the United Kingdom border.